Abstract: In one aspect, the present invention features a tablet including a first drug layer and a second drug layer, wherein: (i) the first drug layer includes first drug particles including naproxen and third drug particles including cetirizine, where the first drug particles and/or the third drug particles are coated with an immediate release coating; and (ii) the second drug layer including pseudoephedrine, wherein said second drug layer is a sustained release layer adapted to deliver a therapeutically effective amount of pseudoephedrine for a period of at least twelve hours.

Abstract: The present invention relates to a gel composition, comprising first and second gel-forming moieties which bind reversibly to one another to form a gel. The binding of the moieties is sensitive to the level of an analyte, and either or both of the gel-forming moieties are attached to cross-linked particulate entities such that the interstices between the entities allow gel-sol and sol-gel transformation, and yet are not so small that the analyte cannot diffuse therethrough. The invention also provides drug delivery systems and sensors for detecting an analyte utilizing such a gel.

Abstract: In one aspect, the present invention features a tablet including a first drug layer, a second drug layer, and a third drug layer, wherein (i) the first drug layer includes naproxen; (ii) a second drug layer including pseudoephedrine; and (iii) the third drug layer includes cetirizine; wherein the first drug layer is in contact with the second drug layer, the third drug layer is in contact with the second drug layer, and the first drug layer is not in contact with the third drug layer, and wherein the second drug layer is a sustained release layer adapted to deliver a therapeutically effective amount of pseudoephedrine for a period of at least twelve hours.

Abstract: A dry powder suitable for inhalation n a dry powder inhaler, the powder comprising a carrier, an active agent and at least 0.5% by weight of magnesium stearate, the powder being further characterized in that the less than 10% of the surface of the carrier material is covered with particles of magnesium stearate. The invention is also directed to a method of making dry powders by blending together the ingredients mentioned in a diffusion blender for a period of time that is less than 60 minutes.

Abstract: According to an aspect of the present invention, the present invention provides medical devices which contain one or more polymeric regions that are at least partially biodisintegrable in bodily fluid. These devices may be implanted or inserted into a subject for treatment of various diseases, disorders and conditions.

Abstract: A process for the preparation of encapsulates, employs: a pumpable emulsion having (i) a continuous phase containing a solvent and a matrix-forming solute dissolved in the solvent and (ii) a dispersed phase; an extractant including supercritical, subcritical or liquefied gas; the solvent being substantially more soluble in the extractant than the matrix-forming solute and the process including the successive steps of: a) combining the pumpable emulsion with the extractant under mixing conditions; b) allowing the formation of particulate encapsulates in which the dispersed phase is encased in a solid matrix of the matrix-forming solute; c) collecting the encapsulates and separating them from the extractant. The present processes is particularly suitable for producing particles containing active ingredients that are very sensitive, whose activity is adversely affected by exposure to oxygen, light, moisture, heat and/or friction.

Abstract: An aqueous hair moisturizing composition is provided. The composition includes a cationic component, an oil containing about 70 percent or greater unsaturated fatty acids with chain length of C18 or greater, a phytosterol and a cellulosic polymer. Also provided is a method of imparting extended moisturization to the hair including the steps of applying to the hair in need of extended moisturization a composition including a cationic component, an oil containing about 70 percent or greater unsaturated fatty acids with chain length of C18 or greater, a phytosterol and a cellulosic polymer, and retaining the composition in contact with the hair for a time sufficient to impart extended moisturization to the hair.

Abstract: An aqueous hair moisturizing composition is provided. The composition includes a cationic component, an oil containing about 70 percent or greater unsaturated fatty acids with chain length of C18 or greater, a phytosterol and a cellulosic polymer. Also provided is a method of imparting extended moisturization to the hair including the steps of applying to the hair in need of extended moisturization a composition including a cationic component, an oil containing about 70 percent or greater unsaturated fatty acids with chain length of C18 or greater, a phytosterol and a cellulosic polymer, and retaining the composition in contact with the hair for a time sufficient to impart extended moisturization to the hair.

Abstract: The present invention provides an effective, all-natural, non-toxic, non-hormonal composition consisting of vitamin D3, vitamin E, selenium, green tea extract, saw palmetto berry extract, isoflavanoids, and lycopene for prostate health. The invention provides compositions and methods to prevent, alleviate, and/or treat symptoms associated with prostate conditions and diseases. The prostate health composition may be used to supplement medical treatment such as radiation therapy, chemotherapy, and hormone therapy.

Abstract: A method for preparing chitosan nanoparticles in water phase is provided. The method comprises the following steps: (a) providing a chitosan solution having a concentration of about 0.05 w/v % to about 1 w/v %, (b) adding water first and then followed by acetic anhydride to the chitosan solution to carry out acetylation, wherein the concentration of acetic anhydride is from about 10 v/v % to about 30 v/v % of the total volume of the whole solution, and (c) subjecting the solution from step (b) to physical dispersion.

Abstract: The present invention relates to a mascara composition including a cosmetically acceptable aqueous medium, characterized in that it includes an oily phase including at least one ethylene/vinyl acetate copolymer, and at least one wax or a mixture of waxes in a certain weight ratio. The present invention also relates to a process for the care or make-up of eyelashes or eyebrows, characterized by the fact that a composition according to the invention is applied to the eyelashes or eyebrows. It also relates to the use of a composition according to the invention in order to obtain a make-up for filling and/or curling the eyelashes and/or a smooth and uniform deposition on the eyelashes.

Abstract: A dry powder suitable for inhalation in a dry powder inhaler, the powder comprising a carrier, an active agent and at least 0.5% by weight of magnesium stearate, the powder being further characterized in that the less than 10% of the surface of the carrier material is covered with particles of magnesium stearate. The invention is also directed to a method of making dry powders by blending together the ingredients mentioned in a diffusion blender for a period time that is less than 60 minutes.

Abstract: This invention provides a tablet that effervesces and significantly warms the water that it is dissolved in. The effervescence acts to break up the tablet allowing an exothermic material to rapidly dissolve releasing its heat of solution. The invention is unique in that no organic acid is required to form a conventional effervescent couple.

Abstract: Coatings for implantable devices or endoluminal prosthesis, such as stents, are provided, including a method of forming the coatings. The coatings can be used for the delivery of an active ingredient or a combination of active ingredients.

Abstract: Implantable medical devices with elastomeric block copolymer coatings are disclosed.

Abstract: A flavored, lubricating solution is applied to a solid medicament by spray, dipping, or otherwise coating the medicament. This liquid coating masks the often objectionable taste of the medicament while lubricating it, and thus significantly improving the ability to swallow the medicament. The improvement to the swallowing process is dramatically enhanced with significant reduction in gag reflex, general un-palatability and inability to move the dosage form completely through the mouth, palate, and esophagus to the stomach without sticking or lodging at any point in the process. The solution is a mixture of viscosity-adhesion-lubricity ingredients which includes polyols and polysaccharides, preservative agents, flavoring agents (to improve the palatability of the solution) and optional dispensing agents.

Abstract: A method of inducing virus tolerance of plants which comprises treating the plants, the soil or seeds with an effective amount of a compound of the formula I.

Abstract: Novel derivatives of ?-cyano-?-naphthyl acrylates, sunscreen compositions including one or more ?-cyano-?-naphthyl acrylate derivatives are described herein. Also disclosed are methods for stabilizing a sunscreen composition and methods of filtering out ultra-violet light from a substrate by the addition of one or more of the foregoing ?-cyano-?-naphthyl acrylate derivatives.

Abstract: A composition comprising at least one aromatic compound and at least one lactate ester compound is provided. Optionally, said composition can further comprise Cloquintocet-mexyl. Optionally, said composition can further comprise at least one emulsifier. Optionally, said composition can further comprise at least one herbicide. Processes comprising mixing such components are provided. Processes for controlling weeds or grasses or both with such compositions are provided.

Abstract: The invention relates to a composition in the form of a positive latex comprising a) between 50 wt. % and 80 wt. % of at least one cross-linked, branched, or linear organic polymer (P), b) between 5 wt. % and 10 wt. % of a water-in-oil (W/O) emulsifying system (S1), c) between 5 wt. % and 45 wt. % of at least one oil, and d) between 0 wt. % and 5 wt. % of water. The inventive composition is characterized in that between 0.01 mol. % and 10 mol. % of the monomeric patterns of said monomer P comprise at least one neutral monomer of formula (I): C(R1)(R3)?C(R2)—C(=0)-0-(CH2—CH2—O)n—R4 (I) wherein the radicals R1, R2 and R3, which are the same or different, independently represent a hydrogen atom or a linear or branched alkyl radical comprising between 1 and 4 carbon atoms, the radical R4 represents a linear or branched, saturated or unsaturated, aliphatic radical comprising between 6 and 30 carbon atoms, and n represents a number between 1 and 50.